Given the observed association between dedifferentiation and enhanced stemness, we hypothesized that IGF2BP2 concurrently promotes cellular dedifferentiation and augments tumor stemness in thyroid carcinoma. Here, IGF2BP2 is linked to thyroid gland carcinoma.